Manorama Industries Appoints New Director, Approves Capital Infusion in Subsidiaries
Manorama Industries appointed Dr. Rohini Tiwari as an Additional Non-Executive Independent Director for five years. The company also approved capital infusions totaling ₹75 crore across six subsidiaries in Ghana, Nigeria, Burkina Faso, Chad, Brazil, and UAE for working capital and operational needs. Mr. Mudit Kumar Singh's tenure as Independent Director concluded.
The appointment of a new director is a standard corporate governance event. However, the substantial capital infusion across multiple subsidiaries indicates a strategic move towards international expansion, which could have a medium-term impact on the company's operations and financial performance.
The appointment of a new independent director and significant capital infusion into subsidiaries for expansion are positive developments for the company's growth prospects.
Manorama Industries Limited announced a significant board meeting outcome on September 4, 2026. The Board of Directors approved the appointment of Dr. Rohini Tiwari as an Additional Director in the category of Non-Executive Independent Director for a term of five consecutive years, effective from September 4, 2026, subject to shareholder approval.
The meeting also approved the cut-off date for the Postal Ballot Notice as September 11, 2026, and appointed M/s Mehta & Mehta, Company Secretaries, as scrutinizers for the postal ballot process. MUFG Intime India Private Limited was engaged to provide the e-voting facility platform for the postal ballot concerning Dr. Tiwari's appointment.
Furthermore, the company approved substantial increases in the share capital of its wholly-owned subsidiaries. This includes up to ₹20 crore in Manorama Savanna Ghana Limited (Ghana), up to ₹10 crore in Manorama Savanna Limited (Nigeria), up to ₹15 crore in Manorama Burkina SARL (Burkina Faso), up to ₹10 crore in Manorama Savannah Agro Chad Sarl (Republic of Chad), up to ₹15 crore in Manorama Latin America LTDA (Brazil), and up to ₹5 crore in Manorama Mena Trading LLC (UAE). These capital infusions are intended for working capital requirements and general corporate purposes to strengthen international operations.
Additionally, the Board noted the completion of the tenure of Mr. Mudit Kumar Singh as an Independent Director, effective September 5, 2026.
A plain-language summary of a public exchange filing by Manorama Industries Limited. Read the original for the full detail.
